
This article highlights that Hungary's life expectancy is 4.5 years below the EU average. The Association of Innovative Pharmaceutical Manufacturers (AIPM) emphasizes the role of innovative therapies in bridging this gap and improving public health. They advocate for better access to modern treatments and increased healthcare funding to enhance the nation's health outcomes.



